@13th_Benedict@jeleston1a Terrible cap raise - from strength to extreme weakness, on par with LDX even without options drag. Oiler raises are often poor but the collapse thru raise price no resistance.
@GameTheory1984 That was 10 days straight down on lowish volume, Heartflow US pushing hard last few days, $4 looks as good as any place to bottom, increased position here 15%. Sapphire or FDA cert and wonβt see $4 again.
$DXB - FDA read-thru to Travere positively received in US. Possible delays, last minute risks re data integrity being priced into DXB, also confirms Travere first to FDA approval, reaffirmation from mgmt on AA path would be handy. Still, 3.6bio USD TVTX moving 10%+ on DXB update
@theAZtrader Yeh majority know pancreatic cancer outcomes worse so valid. Maybe they are holding out for 3rd response (CR)and spike into cap raise, data was solid prior to CRs anyway and nice to see an Oz bio being priced on potential and some animal spirits rather than skepticism
Aus π¦πΊ Bombshell π¨ New Provisions to the Family Law Act taking Effect May 2024 will give the STATE full power to decide who has the rights to decide matters relating To Religious and Medical Beliefs within families..This Means the Govt could remove a Child from an Unvaxxed Parents custody π¨
@theAZtrader been on this for a while as well. cap raise possibility here? at least will be put to good use with these guys racking up plenty of drilling over multiple targets for such a low mkt cap